Suppressing the TLR4 axis using a targeted inhibitor can prevent neuronal loss, and suppress NF‐κB p65 activation following cardiac arrest and cardiopulmonary resuscitation.29, 30. This evidence concerns the gene NFKB1 and cardiac arrest.